Ainex bested global competitors in a supply deal to provide NUH with lower and upper gastrointestinal endoscopy support.The newly opened National University Centre for Di
Ainex's ENAD is an AI-based software as a medical device (SaMD) that supports clinical decision-making by detecting lesions in real time during upper and lower gastrointe
▲ ENAD, Korea's First and Only AI-Assisted Solution Approved for Both Upper and Lower GI Endoscopy▲ ENAD Secures Singapore Hospital Adoption in Competition with
■ Ainex showcases AI-powered real-time diagnostic assistance software ENAD for upper and lower gastrointestinal endoscopy at the Singapore Gastric Cancer Consortium Annua
Ainex Corporation (CEO: David Lee, hereinafter "Ainex"), a medical artificial intelligence (AI) company, announced that it has successfully completed the live demonstrati
Ainex Corporation (CEO: David Lee, hereinafter "Ainex") announced on July 1 that the clinical efficacy and real-world use cases of ENAD were presented at the 2026 Asian O
Field with* are required.
To learn more about our solution, please leave an inquiry.
